Hofseth Biocare (Norway) Buy Hold or Sell Recommendation
| HBC Stock | NOK 1.30 0.01 0.76% |
Assuming the 90 days trading horizon and complete risk avoidance on your part, our recommendation regarding Hofseth Biocare ASA is 'Strong Sell'. The recommendation algorithm takes into account all of Hofseth Biocare's available fundamental, technical, and predictive indicators you will find on this site.
Check out Hofseth Biocare Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Hofseth and provide practical buy, sell, or hold advice based on investors' constraints. Hofseth Biocare ASA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Hofseth |
Execute Hofseth Biocare Buy or Sell Advice
The Hofseth recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Hofseth Biocare ASA. Macroaxis does not own or have any residual interests in Hofseth Biocare ASA or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Hofseth Biocare's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves slightly opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Hofseth Biocare Trading Alerts and Improvement Suggestions
| Hofseth Biocare ASA generated a negative expected return over the last 90 days | |
| Hofseth Biocare ASA may become a speculative penny stock | |
| Hofseth Biocare ASA has high historical volatility and very poor performance | |
| Hofseth Biocare ASA has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 87.62 M. Net Loss for the year was (126.46 M) with profit before overhead, payroll, taxes, and interest of 28.51 M. | |
| Hofseth Biocare ASA has accumulated about 36.52 M in cash with (61.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Roughly 53.0% of the company shares are held by company insiders |
Hofseth Biocare Returns Distribution Density
The distribution of Hofseth Biocare's historical returns is an attempt to chart the uncertainty of Hofseth Biocare's future price movements. The chart of the probability distribution of Hofseth Biocare daily returns describes the distribution of returns around its average expected value. We use Hofseth Biocare ASA price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Hofseth Biocare returns is essential to provide solid investment advice for Hofseth Biocare.
| Mean Return | -0.59 | Value At Risk | -6 | Potential Upside | 4.85 | Standard Deviation | 4.03 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Hofseth Biocare historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Hofseth Biocare Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Hofseth Biocare or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Hofseth Biocare's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Hofseth stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.52 | |
β | Beta against Dow Jones | -0.6 | |
σ | Overall volatility | 4.02 | |
Ir | Information ratio | -0.18 |
Hofseth Biocare Volatility Alert
Hofseth Biocare ASA exhibits very low volatility with skewness of 1.6 and kurtosis of 6.38. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Hofseth Biocare's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Hofseth Biocare's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Hofseth Biocare Fundamentals Vs Peers
Comparing Hofseth Biocare's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Hofseth Biocare's direct or indirect competition across all of the common fundamentals between Hofseth Biocare and the related equities. This way, we can detect undervalued stocks with similar characteristics as Hofseth Biocare or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Hofseth Biocare's fundamental indicators could also be used in its relative valuation, which is a method of valuing Hofseth Biocare by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Hofseth Biocare to competition |
| Fundamentals | Hofseth Biocare | Peer Average |
| Return On Equity | -0.95 | -0.31 |
| Return On Asset | -0.19 | -0.14 |
| Profit Margin | (1.14) % | (1.27) % |
| Operating Margin | (1.07) % | (5.51) % |
| Current Valuation | 1.03 B | 16.62 B |
| Shares Outstanding | 395.08 M | 571.82 M |
| Shares Owned By Insiders | 52.50 % | 10.09 % |
| Shares Owned By Institutions | 20.43 % | 39.21 % |
| Price To Earning | (4.13) X | 28.72 X |
| Price To Book | 5.19 X | 9.51 X |
| Price To Sales | 8.29 X | 11.42 X |
| Revenue | 87.62 M | 9.43 B |
| Gross Profit | 28.51 M | 27.38 B |
| EBITDA | (87.72 M) | 3.9 B |
| Net Income | (126.46 M) | 570.98 M |
| Cash And Equivalents | 36.52 M | 2.7 B |
| Cash Per Share | 0.12 X | 5.01 X |
| Total Debt | 123.31 M | 5.32 B |
| Debt To Equity | 188.20 % | 48.70 % |
| Current Ratio | 1.11 X | 2.16 X |
| Book Value Per Share | 0.39 X | 1.93 K |
| Cash Flow From Operations | (61.78 M) | 971.22 M |
| Earnings Per Share | (0.38) X | 3.12 X |
| Number Of Employees | 9 | 18.84 K |
| Beta | 0.54 | -0.15 |
| Market Capitalization | 1.1 B | 19.03 B |
| Total Asset | 415.97 M | 29.47 B |
| Retained Earnings | (105 M) | 9.33 B |
| Working Capital | (22 M) | 1.48 B |
| Current Asset | 52 M | 9.34 B |
| Current Liabilities | 74 M | 7.9 B |
| Z Score | 4.8 | 8.72 |
| Net Asset | 415.97 M |
Hofseth Biocare Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Hofseth . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Hofseth Biocare Buy or Sell Advice
When is the right time to buy or sell Hofseth Biocare ASA? Buying financial instruments such as Hofseth Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Hofseth Biocare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Real Estate Thematic Idea Now
Real Estate
Publicly traded companies that are involved in real estate development, property maintenance and management of real estate investment trusts (REIT) funds. The Real Estate theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Real Estate Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Hofseth Stock
Hofseth Biocare financial ratios help investors to determine whether Hofseth Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hofseth with respect to the benefits of owning Hofseth Biocare security.